Genotype C is less responsive to treatment with IFN (Wai et al., 2002) and is more likely to be associated with chronic hepatitis and HCC development (Orito et al., 2001; Kobayashi et al., 2002). The gene discussed is IFNA1; the disease is hepatocellular carcinoma.